• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ImmunoGen Inc

+ Add to Watchlist


6.4700 USD 0.1400 2.21%

As of 20:10:00 ET on 01/26/2015.

Snapshot for ImmunoGen Inc (IMGN)

Open: 6.3000 Day's Range: 6.2500 - 6.5100 Volume: 1,017,736
Previous Close: 6.3300 52wk Range: 5.3432 - 17.8000 1-Yr Rtn: -57.49%

Stock Chart for IMGN

No chart data available.
  • IMGN:US 6.4700
  • 1D
  • 1M
  • 1Y
Interactive IMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMGN

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9698
Est. EPS (USD) (06/2015) -0.7050
Est. PEG Ratio -
Market Cap (M USD) 556.00
Shares Outstanding (M) 85.94
30 Day Average Volume 2,195,089
Price/Book (mrq) 9.4276
Price/Sale (ttm) 9.9114
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMGN

ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.

Daniel M Junius "Dan"President/CEODavid B Johnston "Dave"Exec VP/CFO
Sandra E PooleSenior VP:Technical OperationsCharles Q Morris "Charlie"VP/Chief Development Officer
More Company Profile & Key Executives for IMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil